Remote interactions with patients are here to stay. Before COVID-19, only 15% of interactions were remote. Since March 2021, we have seen higher percentages of remote interactions (up to 34%). We seem to have reached the “new normal” with current remote interactions at 26% and future remote interactions expected to be 25% of total patient interactions. While physicians and patients alike likely see benefits in having remote interactions as an option, it does present some challenges as physicians are much more comfortable initiating patients on new drugs in person.
Almost 50% of GPs and almost 30% of specialists say their patients are more or much more engaged in their health. This may reflect a change in what is important to patients or a greater emphasis on health in general since COVID-19. Or it may reflect patients having more time to focus on their health with the changes in other aspects of their lives during COVID-19. Whatever the reason, this increased level of engagement could be useful in ensuring patients seek care when needed and receive a diagnoses sooner.